A revised day + 7 predictive score for transplant-related mortality: Serum cholinesterase, total protein, blood urea nitrogen, γ glutamyl transferase, donor type and cell dose

Bone Marrow Transplantation

Volumn 32, Issue 2, 2003, Pages 205-211

  Sormani, M P ^a   Oneto, R ^a   Bruno, B ^a   Fiorone, M ^a   Lamparelli, T ^a   Gualandi, F ^a   Raiola, A M ^a   Dominieto, A ^a   Van Lint, M T ^a   Frassoni, F ^a   Bruzzi, P ^a   Bacigalupo, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

GvHD; Leukemia

Indexed keywords

ALEMTUZUMAB; BILIRUBIN; CHOLINESTERASE; CYCLOPHOSPHAMIDE; GAMMA GLUTAMYLTRANSFERASE; METHOTREXATE; PROTEIN; THIOTEPA; UREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CALCULATION; CHOLINESTERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; FEMALE; FREQUENCY ANALYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTERNET; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; THROMBOCYTE COUNT; TIME; TRAINING; TREATMENT INDICATION; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BLOOD UREA NITROGEN; CELL COUNT; CHOLINESTERASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TISSUE DONORS;

EID: 10744224819     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704085     Document Type: Article

References (17)

1. Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17: 13.
2. Weiner RS, Bortin MM, Gale RP et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168.
3. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-vs-host disease. Br J Haematol 1987; 67: 397.
4. Weisdorf D, Hakke R, Blazar B et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197.
5. Storb R, Prentice RL, Thomas ED et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 1983; 55: 573.
6. Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729.
7. Bacigalupo A, Oneto R, Bruno B et al. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin. Bone Marrow Transplant 1999; 24: 653-659.
8. Lamparelli T, van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Bone Marrow Transplant 1997; 20: 1057.
9. Bacigalupo A, Oneto R, Bruno B et al. Serum cholinesterase is an early marker of graft versus host disease (GvHD) and transplant related mortality (TRM). Bone Marrow Transplant 2001; 28: 1093-1096.
10. Locasciulli A, Testa M, Valsecchi MG et al. On behalf of the Infectious Diseases-Working Party of the European Blood and Marrow Transplantation Group. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the infectious disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999; 68: 1486-1491.
11. Adler M, Verset D, Bouhdid H, Bourgeois N et al. Prognostic evaluation of patients with parenchymal cirrhosis : proposal of a new simple score. J Hepatol 1997; 26: 642.
12. Garello E, Battista S, Bar F et al. Evaluation of hepatic function in liver cirrosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol and laboratory investigations. Dig Dis Sci 1999; 44: 782.
13. Fink JC, Cooper MA, Burkahrt KM et al. Marked enzymuria after bone marrow transplantation: a correlate of veno occlusive disease induced hepatorenal syndrome. J Am Soc Nephrology 1995; 6: 1655.
14. Cooke KR, Krenger W, Hill G et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 1998; 92: 2571-2580.
15. Panoskaltsis-Mortari A, Strieter RM, Hermanson JR et al. Induction of monocyte and T-cell attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood 2000; 96: 834-839.
16. Ramsay NKC, Kersey JH, Robinson LL et al. A randomized study of the prevention of acute graft versus host disease. N Engl J Med 1982; 306: 392-397.
17. Bacigalupo A, Oneto R, Lamparelli T et al. Pre-emptive therapy of acute graft versus host disease: a pilot study with anti-thymocyte globulin (ATG). Bone Marrow, Transplant 2001; 28: 1093-1096.